# Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia

> **NCT04282629** · PHASE2 · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 234 (estimated)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Milrinone Injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04282629
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-25
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04282629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04282629, "Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04282629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*